Patrick AebischerPatrick Aebischer a achevé une formation en Médecine (1980) et en Neurosciences (1983) aux Universités de Genève et de Fribourg en Suisse.
De 1984 à 1992, Patrick Aebischer a travaillé à Brown University (USA) au sein du Département des Neurosciences et au Département des Biomatériaux et des Organes Artificiels en tant que Professeur assistant, puis Professeur associé.
En 1992, Patrick Aebischer a été nommé Professeur de la Division Autonome de Recherche Chirurgicale et du Centre de Thérapie Génique (DARC) au Centre Hospitalier Universitaire Vaudois (CHUV) à Lausanne.
En 1999, Le Conseil Fédéral a nommé Patrick Aebischer en tant que Président de l'Ecole Polytechnique Fédérale de Lausanne (EPFL). Il a pris ses fonctions à la Présidence de lEPFL en mars 2000, position qu'il a occupée jusqu'au 31 décembre 2016.
Patrick Aebischer est membre de maintes sociétés professionnelles, tant en Europe quaux Etats-Unis.
Patrick Aebischer a fondé trois start-up de biotechnologies. Il siège au conseil d'administration de Lonza, de Logitech et de Nestlé. Il préside également l'advisory board du Novartis Venture Fund. Patrick Aebischer est membre du conseil de fondation du Festival de Jazz de Montreux, du Festival de Verbier et de la Fondation Jacobs.
Les recherches quil poursuit actuellement dans son laboratoire se concentrent sur le développement d'approches de thérapie cellulaire et de transfert génique pour le traitement des maladies neurodégénératives.
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Maria del Carmen Sandi PerezACADEMIC POSITION:
Professor, Director of the Laboratory of Behavioral Genetics, Brain Mind Institute, Ecole Polytechnique Federale de Lausanne (EPFL), Switzerland.
EDUCATION:
BS MS Salamanca, Spain, 1984
PhD Cajal Institute, CSIC, and University Autonoma of Madrid, Spain, 1988
PROFESSIONAL EXPERIENCE:
Postdoc at INSERM, Bordeaux, France, and Cajal Institute Madrid, Spain, 1989-1990
Postdoc at the Open University, UK, 1991-1992, 1996
Research Associate, Cajal Institute, CSIC, Madrid, 1993-1995
Associate Professor Tenured, UNED University, Madrid, 1996-2003
Sabbatical Professor, University of Bern, Switzerland, 2002-2003
Assistant Professor Tenure-Track, EPFL, 2003-2007
Associate Professor Tenured, EPFL, 2007-2012
Full Professor, EPFL, 2012-
Director, Brain Mind Institute, EPFL, 2012-
PRINCIPAL BOARDS:
President, European Brain and Behavior Society (EBBS), 2009-2012
Editor-in-Chief Frontiers in Behavioral Neuroscience
Member of Scientific Advisory Panel, European College Neuropsychopharmacology (ECNP)
Member of the European Dana Alliance for the Brain (EDAB)
Associate Editor Frontiers in Neuroscience
Editorial Board Member Neurobiology of Learning and Memory
Editorial Board Member Journal of Psychiatry Research
Editorial Board Member Stress
Editorial Board Member Biology of Mood and Anxiety Disorders
Editorial Board Member Neuroscience and Biobehavioral Reviews
Francesco MondadaDr. Mondada received his M.Sc. in micro-engineering in 1991 and his Doctoral degree in 1997 at EPFL. During his thesis he co-founded the company K-Team, being both CEO and president of the company for about 5 years. He is one of the three main developers of the Khepera robot, considered as a standard in bio-inspired robotics and used by more than 1,000 universities and research centers worldwide. Fully back in research in 2000 and after a short period at CALTECH, he participated to the SWARM-BOTS project as the main developer of the s-bot robot platform, which was ranked on position 39 in the list of The 50 Best Robots Ever (fiction or real) by the Wired Journal in 2006. The SWARM-BOTS project was selected as FET-IST success story by the EU commission. He is author of more than 100 papers in the field of bio-inspired robotics and system level robot design. He is co-editor of several international conference proceedings. In November 2005 he received the EPFL Latsis University prize for his contributions to bio-inspired robotics. In 2011 he received the "Crédit Suisse Award for Best Teaching" from EPFL and in 2012 the "polysphère" award from the students as best teacher in the school of engineering. His interests include the development of innovative mechatronic solutions for mobile and modular robots, the creation of know-how for future embedded applications, and making robot platforms more accessible for education, research, and industrial development.
Grégoire CourtineGrégoire Courtine was originally trained in Mathematics and Physics, but received his PhD degree in Experimental Medicine from the University of Pavia, Italy, and the INSERM Plasticity and Motricity, in France, in 2003. From 2004-2007, he held a Post-doctoral Fellow position at the Brain Research Institute, University of California at Los Angeles (UCLA) under the supervision of Dr. Reggie Edgerton, and was a research associate for the Christopher and Dana Reeve Foundation (CDRF). In 2008, he became Assistant Professor at the faculty of Medicine of the University of Zurich where he established his own research laboratory. In 2012, he was nominated Associate Professor at the Swiss Federal Institute of Technology Lausanne (EPFL) where he holds the International paraplegic foundation (IRP) chair in spinal cord repair at the Center for Neuroprosthetics and the Brain Mind Institute. He published several articles proposing radically new approaches for restoring function after spinal cord injury, which were discussed in national and international press extensively. He received numerous honors and awards such as the 2007 UCLA Chancellors award for excellence in post-doctoral research and the 2009 Schellenberg Prize for his innovative research in spinal cord injury awarded by the International Foundation of Research in Paraplegia.
Marcello IencaDr. Marcello Ienca is a Principal Investigator at the College of Humanities at EPFL where he leads the ERA-NET funded Intelligent Systems Ethics research unit. He is also an affiliate member of the Health Ethics and Policy unit, Department of Health Sciences and Technology, and an ordinary member of the
Competence for Rehabilitation Engineering & Science
at ETH Zurich, Switzerland.
Dr. Ienca's scholarship focuses on the ethical, legal, social and policy implications of emerging technologies. In particular, he investigates the broader implications of new (and often converging) sociotechnical trends such as Artificial Intelligence (AI), big data, digital epidemiology, robotics, assisted living, digital health, social media, dual use, and neurotechnology. He and his team use both theoretical and empirical methods to explore the requirements for responsible innovation, ethically-aligned technology design, user-centred design, and human-centered technology assessment.
Dr. Ienca is actively involved in science and technology policy within international organizations and professional societies. In particular, he is an appointed member of the Organisation for Economic Co-operation and Development’s (OECD) Steering Committee on Neurotechnology and the representative of the Swiss Delegation (appointed by the Swiss State Secretariat for Education, Research and Innovation, SERI). He has also been invited to serve as an expert advisor to the Council of Europe’s Ad Hoc Committee on Artificial Intelligence and the Bioethics Committee. Dr. Ienca has written reports for the OECD, the Council of Europe, and the European Parliament's Panel for the Future of Science and Technology. He is a Member of the Board of Directors of the Italian Neuroethics Society (SINe), a former Board Member and current member of the Nominating Committee of the International Neuroethics Society (INS). Ienca is a member of the Editorial Board of several academic journals such as Neuroethics, Bioethica Forum, Frontiers in Neuroergonomics and Frontiers in Genetics.
Ienca has received several awards for social responsibility in science and technology such as the Vontobel Award for Ageing Research (Switzerland), the Prize Pato de Carvalho (Portugal), the Sonia Lupien Award (Canada), the Paul Schotsmans Prize from the European Association of Centres of Medical Ethics (EACME) and the Data Privacy Plaque of Honour, awarded by the Italian Data Protection Authority. He has authored one monograph, several edited volumes, 60 scientific articles in peer-review journals, several book chapters and is a frequent contributor to Scientific American. His research was featured in academic journals such as
Neuron
,
Nature Biotechnology
,
Nature Machine Intelligence
,
Nature Medicine
and media outlets such as
Nature
,
The New Yorker
,
The Guardian
,
The Times
,
Die Welt
,
The Independent
, the
Financial Times
and others.
Furthermore, Dr. Ienca strongly supports open science, outreach and public engagement. He is committed to a holistic view of research that is not restricted to academia alone but involves an open approach to science communication, outreach and public engagement. Among other things, he is an open-science and open-data enthusiast and a human rights activist. He believes that there can be no ethical technological innovation without global justice.
Rolf GruetterAwards:
1999 Young Investigator Award Plenary Lectureship
, International Society for Neurochemistry
2011 Fellow
, ESMRMB
2011 Teaching Award
, Section Sciences de la Vie, EPFL
